Form 4: ARDX CEO Sells Shares for Tax Cover

ARDELYX CEO Michael Raab sold 54,748 shares of common stock to cover tax obligations related to RSU vesting.

Summary

• Michael Raab, President & CEO and Director of ARDELYX, INC. (ARDX), reported transactions involving the company's common stock.
• He sold a total of 54,748 shares of ARDX common stock on May 21, 2026.
• The sales were executed at a price of $6.2675 per share.
• These sales were an automatic 'sell-to-cover' transaction to satisfy withholding taxes upon the vesting of Restricted Stock Units (RSUs).
• Following these transactions, Mr. Raab directly beneficially owns 1,720,033 shares and indirectly owns 25,364 shares through family trusts.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a routine, non-discretionary sale for tax purposes upon RSU vesting, which does not typically reflect a change in the executive's outlook on the company's performance.

Positives

• The transaction represents the vesting of Restricted Stock Units (RSUs), indicating the executive is receiving equity compensation as part of their remuneration package.

Negatives

• A reduction in the direct beneficial ownership of common stock by a key executive, although for a non-discretionary reason.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it primarily reports past insider transactions.

Management Comments

• "Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ('RSUs') awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."

Industry Context

StockSavvy.ai notes that 'sell-to-cover' transactions are a common and routine occurrence for executives receiving equity compensation, particularly Restricted Stock Units (RSUs). These sales are typically non-discretionary and are executed to satisfy tax obligations upon vesting, rather than signaling a change in management's confidence or a strategic divestment.

Comparison to Industry Standards

• This type of 'sell-to-cover' transaction is a standard practice across various industries, including biotechnology and pharmaceuticals, where equity compensation forms a significant part of executive remuneration.
• Many public companies, such as those in the S&P 500, frequently report similar Form 4 filings from their executives, indicating the routine nature of such tax-related sales upon RSU vesting.

Related Party Transactions

• Indirect beneficial ownership of 24,364 common shares is held by Michael G. Raab, Trustee of the Michael G. Raab Living Trust dated July 25, 2012.
• Indirect beneficial ownership of 1,000 common shares is held by trusts for the benefit of the Reporting Person's children.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not indicative of a change in executive confidence or company fundamentals.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary 'sell-to-cover' transaction by the CEO to satisfy tax obligations upon RSU vesting. Such sales are common and generally do not reflect a change in management's outlook or confidence in the company. Therefore, it provides no new fundamental information to alter an existing investment thesis, warranting a 'hold' recommendation.

Keywords

ARDELYX, ARDX, Michael Raab, Form 4, insider transaction, stock sale, RSU vesting, tax withholding, CEO, director